Publicaciones en colaboración con investigadores/as de Universidad del País Vasco/Euskal Herriko Unibertsitatea (31)

2023

  1. Preparation of Selenium-Based Drug-Modified Polymeric Ligand-Functionalised Fe3O4 Nanoparticles as Multimodal Drug Carrier and Magnetic Hyperthermia Inductor

    Pharmaceuticals, Vol. 16, Núm. 7

2021

  1. Transfer of SCN1A to the brain of adolescent mouse model of Dravet syndrome improves epileptic, motor, and behavioral manifestations

    Molecular Therapy - Nucleic Acids, Vol. 25, pp. 585-602

2020

  1. Cells, Materials, and Fabrication Processes for Cardiac Tissue Engineering

    Frontiers in Bioengineering and Biotechnology, Vol. 8

2019

  1. Preclinical safety of topically administered nanostructure lipid carriers (NLC) for wound healing application: biodistribution and toxicity studies

    International Journal of Pharmaceutics, Vol. 569

2018

  1. Plasma rich in growth factors membrane as coadjuvant treatment in the surgery of ocular surface disorders

    Medicine (United States), Vol. 97, Núm. 17

2017

  1. Autologous method for ex vivo expansion of human limbal epithelial progenitor cells based on plasma rich in growth factors technology

    Ocular Surface, Vol. 15, Núm. 2, pp. 248-256

  2. The Use of Fluoroproline in MUC1 Antigen Enables Efficient Detection of Antibodies in Patients with Prostate Cancer

    Journal of the American Chemical Society, Vol. 139, Núm. 50, pp. 18255-18261

2015

  1. Population pharmacokinetic models for cefuroxime and metronidazole used in combination as prophylactic agents in colorectal surgery: Model-based evaluation of standard dosing regimens

    International Journal of Antimicrobial Agents, Vol. 45, Núm. 5, pp. 504-511

2014

  1. Population pharmacokinetics of piperacillin and tazobactam in critically ill patients undergoing continuous renal replacement therapy: Application to pharmacokinetic/pharmacodynamic analysis

    Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 1, pp. 180-189

2012

  1. Long lasting effects of early-life stress on glutamatergic/GABAergic circuitry in the rat hippocampus

    Neuropharmacology, Vol. 62, Núm. 5-6, pp. 1944-1953

  2. Population pharmacokinetics of prophylactic cefoxitin in patients undergoing colorectal surgery

    European Journal of Clinical Pharmacology, Vol. 68, Núm. 5, pp. 735-745

2011

  1. Pharmacokinetic/pharmacodynamic evaluation of amoxicillin, amoxicillin/clavulanate and ceftriaxone in the treatment of paediatric acute otitis media in Spain

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 3, pp. 167-173

2010

  1. A semi-physiological-based pharmacokinetic/pharmacodynamic model to describe the effects of topotecan on B-lymphocyte lineage cells

    Pharmaceutical Research, Vol. 27, Núm. 3, pp. 431-441

2008

  1. Population pharmacokinetics of meropenem in critically ill patients undergoing continuous renal replacement therapy

    Clinical Pharmacokinetics, Vol. 47, Núm. 3, pp. 173-180

2000

  1. Alpha1-acid glycoprotein (AAG) and serum protein binding of methadone in heroin addicts with abstinence syndrome

    International Journal of Clinical Pharmacology and Therapeutics, Vol. 38, Núm. 1, pp. 35-40

  2. Modeling of the in vivo antinociceptive interaction between an opioid agonist, (+)-O-desmethyltramadol, and a monoamine reuptake inhibitor, (-)-O-desmethyltramadol, in rats

    Journal of Pharmacology and Experimental Therapeutics, Vol. 295, Núm. 1, pp. 352-359

  3. Pharmacokinetic-pharmacodynamic modeling of the antinociceptive effects of main active metabolites of tramadol, (+)-O-desmethyltramadol and (-)-O- desmethyltramadol, in rats

    Journal of Pharmacology and Experimental Therapeutics, Vol. 293, Núm. 2, pp. 646-653

  4. Pharmacokinetic-pharmacodynamic modelling of the antipyretic effect of two oral formulations of ibuprofen

    Clinical Pharmacokinetics, Vol. 38, Núm. 6, pp. 505-518

1999

  1. Altered plasma and brain disposition and pharmacodynamics of methadone in abstinent rats

    Journal of Pharmacology and Experimental Therapeutics, Vol. 288, Núm. 1, pp. 179-187

  2. Enantiomeric separation of tramadol and its active metabolite in human plasma by chiral high-performance liquid chromatography: Application to pharmacokinetic studies

    Chirality, Vol. 11, Núm. 4, pp. 272-279